V012-0369 Screening compound: N-(2,6-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide

V012-0369 Screening compound: N-(2,6-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide
V012-0369 Screening compound: N-(2,6-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-0369
N-(2,6-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-0369

Molecular Formula

C25H29Cl2N5O4 (C25 H29 Cl2 N5 O4)

Compound Name

N-(2,6-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxamide

IUPAC name

N-(26-dichlorophenyl)-3-{[(2-methoxyethyl)carbamoyl]methyl}-4-oxo-1-phenyl-138-triazaspiro[4.5]decane-8-carboxamide

SMILES

COCCNC(CN(CN(C1(CC2)CCN2C(Nc(c(Cl)ccc2)c2Cl)=O)c2ccccc2)C1=O)=O

InChI

InChI=1S/C25H29Cl2N5O4/c1-36-15-12-28-21(33)16-31-17-32(18-6-3-2-4-7-18)25(23(31)34)10-13-30(14-11-25)24(35)29-22-19(26)8-5-9-20(22)27/h2-9H,10-17H2,1H3,(H,28,33)(H,29,35)

InChI Key

DZDRTQWHANYPIU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19726119

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

534.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.534

Distribution Coefficient, logD

3.533

Water Solubility, LogSw

-3.69

Polar Surface Area

77.256

Acid Dissociation Constant (pKa)

10.26

Base Dissociation Constant (pKb)

1.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V012-0369 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V012-0369 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-0369?
Check Price and Availability of V012-0369, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-0369 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-0369
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-0369
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-0369 available by request